Mesenchymal Stem Cells Antagonize IFN-Induced Proinflammatory Changes and Growth Inhibition Effects via Wnt/β-Catenin and JAK/STAT Pathway in Human Outer Root Sheath Cells and Hair Follicles

    Yujin Lee, Song-Hee Park, Hye-Ree Park, Young Lee, Hoon Kang, Jung Eun Kim
    New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide →
    Studysummary This study found that human hematopoietic mesenchymal stem cells increased the viability and migration of human outer root sheath cells in an in vitro alopecia areata model, involving Wnt/β-catenin and JAK/STAT pathways. Our plain-language summary of this paper — not a Tressless recommendation.
    The study demonstrated that mesenchymal stem cell therapy (MSCT) could counteract interferon-gamma (IFN-γ)-induced proinflammatory changes and growth inhibition in human outer root sheath cells (hORSCs) and hair follicles (HFs) by modulating the Wnt/β-catenin and JAK/STAT pathways. MSCT increased hair growth factors, improved cell viability and migration, and promoted hair growth in an ex vivo mouse model. These findings suggested that MSCT could be a promising therapeutic approach for conditions like alopecia areata (AA) by promoting hair growth and reducing inflammation.
    Discuss this study in the Community →

    Research cited in this study

    25 / 25 results